1-6 of 6
Allison Betof Warner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Early On-Treatment Assessment of T Cells, Cytokines, and Tumor DNA with Adaptively Dosed Nivolumab + Ipilimumab: Final Results from the Phase 2 ADAPT-IT Study

James W. Smithy, Hannah L. Kalvin, Fiona D. Ehrich, Ronak Shah, Matthew Adamow, Vladislav Raber, Collen A. Maher, Jenna Kleman, Deborah A.G. McIntyre, Alexander N. Shoushtari, Allison Betof Warner, Margaret K. Callahan, Parisa Momtaz, Omar Eton, Suresh Nair, Jedd D. Wolchok, Paul B. Chapman, Michael F. Berger, Katherine S. Panageas, Michael A. Postow
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (16): 3407–3415.
https://doi.org/10.1158/1078-0432.CCR-23-3643
Published: 15 August 2024
View article titled, Early On-Treatment Assessment of T Cells, Cytokines, and Tumor DNA with Adaptively Dosed Nivolumab + Ipilimumab: Final Results from the Phase 2 ADAPT-IT Study
Open the PDF for Early On-Treatment Assessment of T Cells, Cytokines, and Tumor DNA with Adaptively Dosed Nivolumab + Ipilimumab: Final Results from the Phase 2 ADAPT-IT Study in another window
Includes: Supplementary data
Journal Articles

CD4+ TIL to the Rescue of Anti–PD-1 Failure by Targeting MHC-II

Allison Betof Warner, Jason J. Luke
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (19): 3829–3831.
https://doi.org/10.1158/1078-0432.CCR-23-1333
Published: 02 October 2023
View article titled, CD4<sup>+</sup> TIL to the Rescue of Anti–PD-1 Failure by Targeting MHC-II
Open the PDF for CD4<sup>+</sup> TIL to the Rescue of Anti–PD-1 Failure by Targeting MHC-II in another window
Journal Articles

Tumor-Infiltrating Lymphocyte Therapy in Melanoma: Facts to the Future

Allison Betof Warner, Pippa G. Corrie, Omid Hamid
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (10): 1835–1854.
https://doi.org/10.1158/1078-0432.CCR-22-1922
Published: 15 May 2023
View article titled, Tumor-Infiltrating Lymphocyte Therapy in Melanoma: Facts to the Future
Open the PDF for Tumor-Infiltrating Lymphocyte Therapy in Melanoma: Facts to the Future in another window
Journal Articles

Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti–PD-1 Monotherapy

Xue Bai, Jiani Hu, Allison Betof Warner, Henry T. Quach, Christopher G. Cann, Michael Z. Zhang, Lu Si, Bixia Tang, Chuanliang Cui, Xiaoling Yang, Xiaoting Wei, Lalit Pallan, Catriona Harvey, Michael P. Manos, Olivia Ouyang, Michelle S. Kim, Gyulnara Kasumova, Justine V. Cohen, Donald P. Lawrence, Christine Freedman, Riley M. Fadden, Krista M. Rubin, Tatyana Sharova, Dennie T. Frederick, Keith T. Flaherty, Osama E. Rahma, Georgina V. Long, Alexander M. Menzies, Jun Guo, Alexander N. Shoushtari, Douglas B. Johnson, Ryan J. Sullivan, Genevieve M. Boland
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (21): 5993–6000.
https://doi.org/10.1158/1078-0432.CCR-21-1283
Published: 01 November 2021
View article titled, Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti–PD-1 Monotherapy
Open the PDF for Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti–PD-1 Monotherapy in another window
Includes: Supplementary data
Journal Articles

Therapeutic Implications of Detecting MAPK-Activating Alterations in Cutaneous and Unknown Primary Melanomas

Alexander N. Shoushtari, Walid K. Chatila, Arshi Arora, Francisco Sanchez-Vega, Havish S. Kantheti, Jorge A. Rojas Zamalloa, Penina Krieger, Margaret K. Callahan, Allison Betof Warner, Michael A. Postow, Parisa Momtaz, Suresh Nair, Charlotte E. Ariyan, Christopher A. Barker, Mary Susan Brady, Daniel G. Coit, Neal Rosen, Paul B. Chapman, Klaus J. Busam, David B. Solit, Katherine S. Panageas, Jedd D. Wolchok, Nikolaus Schultz
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (8): 2226–2235.
https://doi.org/10.1158/1078-0432.CCR-20-4189
Published: 15 April 2021
View article titled, Therapeutic Implications of Detecting MAPK-Activating Alterations in Cutaneous and Unknown Primary Melanomas
Open the PDF for Therapeutic Implications of Detecting MAPK-Activating Alterations in Cutaneous and Unknown Primary Melanomas in another window
Includes: Supplementary data
Journal Articles

Bigger Is Not Always Better: Tumor Size and Prognosis in Advanced Melanoma

Allison Betof Warner, Michael A. Postow
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (20): 4915–4917.
https://doi.org/10.1158/1078-0432.CCR-18-1311
Published: 15 October 2018
View article titled, Bigger Is Not Always Better: Tumor Size and Prognosis in Advanced Melanoma
Open the PDF for Bigger Is Not Always Better: Tumor Size and Prognosis in Advanced Melanoma in another window